1
|
Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999; 99:13-22. [PMID: 10520990 DOI: 10.1016/s0092-8674(00)80058-6] [Citation(s) in RCA: 827] [Impact Index Per Article: 31.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Herpes simplex virus type 1 (HSV-1) binds to cells through interactions of viral glycoproteins gB and gC with heparan sulfate chains on cell surface proteoglycans. This binding is not sufficient for viral entry, which requires fusion between the viral envelope and cell membrane. Here, we show that heparan sulfate modified by a subset of the multiple D-glucosaminyl 3-O-sulfotransferase isoforms provides sites for the binding of a third viral glycoprotein, gD, and for initiation of HSV-1 entry. We conclude that susceptibility of cells to HSV-1 entry depends on (1) presence of heparan sulfate chains to which virus can bind and (2) 3-O-sulfation of specific glucosamine residues in heparan sulfate to generate gD-binding sites or the expression of other previously identified gD-binding receptors.
Collapse
|
|
26 |
827 |
2
|
Zhang H, Cai D, Bai X. Macrophages regulate the progression of osteoarthritis. Osteoarthritis Cartilage 2020; 28:555-561. [PMID: 31982565 DOI: 10.1016/j.joca.2020.01.007] [Citation(s) in RCA: 307] [Impact Index Per Article: 61.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2019] [Revised: 01/06/2020] [Accepted: 01/10/2020] [Indexed: 02/02/2023]
Abstract
OA is now well accepted as a low-grade inflammatory disease affecting the whole joint. In addition to mechanical loading, inflammation (particularly synovitis), contributes significantly to OA. Synovial macrophages act as immune cells and are of critical importance in the symptomology and structural progression of OA. Activated macrophages are regulated by mTOR, NF-κB, JNK, PI3K/Akt and other signaling pathways, and are polarized into either M1 or M2 subtypes in OA synovial tissues, synovial fluid, and peripheral blood. The activation state and the M1/M2 ratio is highly associated with OA severity. Aside from autocrine interactions, paracrine interactions between macrophages and chondrocytes play a vital role in the initiation and development of OA by secreting inflammatory cytokines, growth factors, matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs), which lead to subsequent cartilage degradation and destruction. Treatments targeting synovial macrophages relieve pain, and protect from synovitis, cartilage damage, and osteophyte formation during OA development. Macrophage reprogramming of transformation from the M1 to M2 subtype, more than a decrease in the quantity of activated macrophages, appears to be an effective treatment option for OA. This review provides a broad understanding of the contributions of polarized macrophages to joint health and disease. Multifunctional agents with immunomodulatory effects on macrophage reprogramming can skew the inflammatory microenvironment towards a pro-chondrogenic atmosphere, and are thus, potential therapeutic options for the treatment of OA and other immune diseases.
Collapse
|
Review |
5 |
307 |
3
|
Aartsen MG, Abraham K, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Altmann D, Anderson T, Archinger M, Arguelles C, Arlen TC, Auffenberg J, Bai X, Barwick SW, Baum V, Bay R, Beatty JJ, Tjus JB, Becker KH, Beiser E, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Braun J, Brayeur L, Bretz HP, Brown AM, Buzinsky N, Casey J, Casier M, Cheung E, Chirkin D, Christov A, Christy B, Clark K, Classen L, Coenders S, Cowen DF, Silva AHC, Daughhetee J, Davis JC, Day M, André JPAMD, Clercq CD, Dembinski H, Ridder SD, Desiati P, Vries KDD, Wasseige GD, With MD, DeYoung T, Díaz-Vélez JC, Dumm JP, Dunkman M, Eagan R, Eberhardt B, Ehrhardt T, Eichmann B, Euler S, Evenson PA, Fadiran O, Fahey S, Fazely AR, Fedynitch A, Feintzeig J, Felde J, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Fuchs T, Gaisser TK, Gaior R, Gallagher J, Gerhardt L, Ghorbani K, Gier D, Gladstone L, Glagla M, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, et alAartsen MG, Abraham K, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Altmann D, Anderson T, Archinger M, Arguelles C, Arlen TC, Auffenberg J, Bai X, Barwick SW, Baum V, Bay R, Beatty JJ, Tjus JB, Becker KH, Beiser E, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Braun J, Brayeur L, Bretz HP, Brown AM, Buzinsky N, Casey J, Casier M, Cheung E, Chirkin D, Christov A, Christy B, Clark K, Classen L, Coenders S, Cowen DF, Silva AHC, Daughhetee J, Davis JC, Day M, André JPAMD, Clercq CD, Dembinski H, Ridder SD, Desiati P, Vries KDD, Wasseige GD, With MD, DeYoung T, Díaz-Vélez JC, Dumm JP, Dunkman M, Eagan R, Eberhardt B, Ehrhardt T, Eichmann B, Euler S, Evenson PA, Fadiran O, Fahey S, Fazely AR, Fedynitch A, Feintzeig J, Felde J, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Fuchs T, Gaisser TK, Gaior R, Gallagher J, Gerhardt L, Ghorbani K, Gier D, Gladstone L, Glagla M, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grant D, Gretskov P, Groh JC, Gross A, Ha C, Haack C, Ismail AH, Hallgren A, Halzen F, Hansmann B, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hellwig D, Hickford S, Hignight J, Hill GC, Hoffman KD, Hoffmann R, Holzapfel K, Homeier A, Hoshina K, Huang F, Huber M, Huelsnitz W, Hulth PO, Hultqvist K, In S, Ishihara A, Jacobi E, Japaridze GS, Jero K, Jurkovic M, Kaminsky B, Kappes A, Karg T, Karle A, Kauer M, Keivani A, Kelley JL, Kemp J, Kheirandish A, Kiryluk J, Kläs J, Klein SR, Kohnen G, Kolanoski H, Konietz R, Koob A, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krings K, Kroll G, Kroll M, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Lanfranchi JL, Larson MJ, Lesiak-Bzdak M, Leuermann M, Leuner J, Lünemann J, Madsen J, Maggi G, Mahn KBM, Maruyama R, Mase K, Matis HS, Maunu R, McNally F, Meagher K, Medici M, Meli A, Menne T, Merino G, Meures T, Miarecki S, Middell E, Middlemas E, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Olivas A, Omairat A, O’Murchadha A, Palczewski T, Paul L, Pepper JA, Heros CPDL, Pfendner C, Pieloth D, Pinat E, Posselt J, Price PB, Przybylski GT, Pütz J, Quinnan M, Rädel L, Rameez M, Rawlins K, Redl P, Reimann R, Relich M, Resconi E, Rhode W, Richman M, Richter S, Riedel B, Robertson S, Rongen M, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Sabbatini L, Sander HG, Sandrock A, Sandroos J, Sarkar S, Schatto K, Scheriau F, Schimp M, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönwald A, Schukraft A, Schulte L, Seckel D, Seunarine S, Shanidze R, Smith MWE, Soldin D, Spiczak GM, Spiering C, Stahlberg M, Stamatikos M, Stanev T, Stanisha NA, Stasik A, Stezelberger T, Stokstad RG, Stössl A, Strahler EA, Ström R, Strotjohann NL, Sullivan GW, Sutherland M, Taavola H, Taboada I, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale PA, Tobin MN, Tosi D, Tselengidou M, Unger E, Usner M, Vallecorsa S, Vandenbroucke J, Eijndhoven NV, Vanheule S, Santen JV, Veenkamp J, Vehring M, Voge M, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandkowsky N, Weaver C, Wendt C, Westerhoff S, Whelan BJ, Whitehorn N, Wichary C, Wiebe K, Wiebusch CH, Wille L, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu DL, Xu XW, Xu Y, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Zoll M. A COMBINED MAXIMUM-LIKELIHOOD ANALYSIS OF THE HIGH-ENERGY ASTROPHYSICAL NEUTRINO FLUX MEASURED WITH ICECUBE. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0004-637x/809/1/98] [Show More Authors] [Citation(s) in RCA: 288] [Impact Index Per Article: 28.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
|
10 |
288 |
4
|
Armstrong RC, Aja T, Xiang J, Gaur S, Krebs JF, Hoang K, Bai X, Korsmeyer SJ, Karanewsky DS, Fritz LC, Tomaselli KJ. Fas-induced activation of the cell death-related protease CPP32 Is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 1996; 271:16850-5. [PMID: 8663439 DOI: 10.1074/jbc.271.28.16850] [Citation(s) in RCA: 232] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
The human proto-oncogene bcl-2 and its Caenorhabditis elegans homologue ced-9 inhibit programmed cell death. In contrast, members of the human interleukin-1beta converting enzyme (ICE) family of cysteine proteases and their C. elegans homologue CED-3 promote the death program. Genetic experiments in C. elegans have shown that ced-9 is formally a negative regulator of ced-3 function, but neither those studies nor others have determined whether CED-9 or Bcl-2 proteins act biochemically upstream or downstream of CED-3/ICE proteases. CPP32, like all known members of the CED-3/ICE family, is synthesized as a proenzyme that is subsequently processed into an active protease with specificity for cleavage at Asp-X peptide bonds. In this report, we demonstrate that the CPP32 proenzyme is proteolytically processed and activated in Jurkat cells induced to die by Fas ligation. CPP32 activation is blocked by cell-permeable inhibitors of aspartate-directed, cysteine proteases, suggesting that pro-CPP32 is cleaved by active CPP32 or by other ICE family members. Heterologous expression of Bcl-2 in Jurkat cells prevents Fas-induced cell death as well as proteolytic processing and activation of CPP32. Thus, Bcl-2 acts at or upstream of the CPP32 activation step to inhibit apoptosis induced by Fas stimulation.
Collapse
|
|
29 |
232 |
5
|
Mittl PR, Di Marco S, Krebs JF, Bai X, Karanewsky DS, Priestle JP, Tomaselli KJ, Grütter MG. Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone. J Biol Chem 1997; 272:6539-47. [PMID: 9045680 DOI: 10.1074/jbc.272.10.6539] [Citation(s) in RCA: 194] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
The cysteine protease CPP32 has been expressed in a soluble form in Escherichia coli and purified to >95% purity. The three-dimensional structure of human CPP32 in complex with the irreversible tetrapeptide inhibitor acetyl-Asp-Val-Ala-Asp fluoromethyl ketone was determined by x-ray crystallography at a resolution of 2.3 A. The asymmetric unit contains a (p17/p12)2 tetramer, in agreement with the tetrameric structure of the protein in solution as determined by dynamic light scattering and size exclusion chromatography. The overall topology of CPP32 is very similar to that of interleukin-1beta-converting enzyme (ICE); however, differences exist at the N terminus of the p17 subunit, where the first helix found in ICE is missing in CPP32. A deletion/insertion pattern is responsible for the striking differences observed in the loops around the active site. In addition, the P1 carbonyl of the ketone inhibitor is pointing into the oxyanion hole and forms a hydrogen bond with the peptidic nitrogen of Gly-122, resulting in a different state compared with the tetrahedral intermediate observed in the structure of ICE and CPP32 in complex with an aldehyde inhibitor. The topology of the interface formed by the two p17/p12 heterodimers of CPP32 is different from that of ICE. This results in different orientations of CPP32 heterodimers compared with ICE heterodimers, which could affect substrate recognition. This structural information will be invaluable for the design of small synthetic inhibitors of CPP32 as well as for the design of CPP32 mutants.
Collapse
|
|
28 |
194 |
6
|
Wang CY, Bai XY, Wang CH. Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development. THE AMERICAN JOURNAL OF CHINESE MEDICINE 2014; 42:543-59. [PMID: 24871650 DOI: 10.1142/s0192415x14500359] [Citation(s) in RCA: 189] [Impact Index Per Article: 17.2] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
To discover and develop novel natural compounds, active ingredients, single herbs and combination formulas or prescriptions in traditional Chinese medicine (TCM) with therapeutic selectivity that can preferentially kill cancer cells and inhibit the amplification of cancer without significant toxicity is an important area in cancer therapy. A lot of valuable TCMs were applied as alternative or complementary medicines in the United States and Europe. But these TCMs, as one of the main natural resources, were widely used to research and develop new drugs in Asia. In TCMs, some specific herbs, animals, minerals and combination formulas were recorded and exploited due to their active ingredients and specific natural compounds with antitumor activities. The article focused on the antitumor properties of natural compounds and combination formulas or prescriptions in TCMs, described its influence on tumor progression, angiogenesis, metastasis, and revealed its mechanisms of antitumor and inhibitory action. Among the nature compounds, triptolide, berberine, matrine, oxymatrine, kurarinone and deoxypodophyllotoxin (DPT) with specific molecular structures have been separated, purified, and evaluated their antitumor properties in vitro and in vivo. Cancer is a multifactorial and multistep disease, so the treatment effect of combination formulas and prescriptions in TCMs involving multi-targets and multi-signal pathways on tumor may be superior than that of agents targeting a single molecular target alone. Shi Quan Da Bu Tang and Yanshu injection, as well known combination formulas and prescriptions in TCMs, have shown an excellent therapeutic effect on cancer.
Collapse
|
Review |
11 |
189 |
7
|
Aartsen MG, Abbasi R, Abdou Y, Ackermann M, Adams J, Aguilar JA, Ahlers M, Altmann D, Auffenberg J, Bai X, Baker M, Barwick SW, Baum V, Bay R, Beatty JJ, Bechet S, Becker Tjus J, Becker KH, Benabderrahmane ML, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Bertrand D, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohaichuk S, Bohm C, Bose D, Böser S, Botner O, Brayeur L, Bretz HP, Brown AM, Bruijn R, Brunner J, Carson M, Casey J, Casier M, Chirkin D, Christov A, Christy B, Clark K, Clevermann F, Coenders S, Cohen S, Cowen DF, Cruz Silva AH, Danninger M, Daughhetee J, Davis JC, Day M, De Clercq C, De Ridder S, Desiati P, de Vries KD, de With M, DeYoung T, Díaz-Vélez JC, Dunkman M, Eagan R, Eberhardt B, Eichmann B, Eisch J, Ellsworth RW, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feintzeig J, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Franckowiak A, Frantzen K, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grandmont DT, Grant D, Groß A, Ha C, Haj Ismail A, et alAartsen MG, Abbasi R, Abdou Y, Ackermann M, Adams J, Aguilar JA, Ahlers M, Altmann D, Auffenberg J, Bai X, Baker M, Barwick SW, Baum V, Bay R, Beatty JJ, Bechet S, Becker Tjus J, Becker KH, Benabderrahmane ML, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Bertrand D, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohaichuk S, Bohm C, Bose D, Böser S, Botner O, Brayeur L, Bretz HP, Brown AM, Bruijn R, Brunner J, Carson M, Casey J, Casier M, Chirkin D, Christov A, Christy B, Clark K, Clevermann F, Coenders S, Cohen S, Cowen DF, Cruz Silva AH, Danninger M, Daughhetee J, Davis JC, Day M, De Clercq C, De Ridder S, Desiati P, de Vries KD, de With M, DeYoung T, Díaz-Vélez JC, Dunkman M, Eagan R, Eberhardt B, Eichmann B, Eisch J, Ellsworth RW, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feintzeig J, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Franckowiak A, Frantzen K, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grandmont DT, Grant D, Groß A, Ha C, Haj Ismail A, Hallen P, Hallgren A, Halzen F, Hanson K, Heereman D, Heinen D, Helbing K, Hellauer R, Hickford S, Hill GC, Hoffman KD, Hoffmann R, Homeier A, Hoshina K, Huelsnitz W, Hulth PO, Hultqvist K, Hussain S, Ishihara A, Jacobi E, Jacobsen J, Jagielski K, Japaridze GS, Jero K, Jlelati O, Kaminsky B, Kappes A, Karg T, Karle A, Kelley JL, Kiryluk J, Kläs J, Klein SR, Köhne JH, Kohnen G, Kolanoski H, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krasberg M, Krings K, Kroll G, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Landsman H, Larson MJ, Lesiak-Bzdak M, Leuermann M, Leute J, Lünemann J, Madsen J, Maggi G, Maruyama R, Mase K, Matis HS, McNally F, Meagher K, Merck M, Meures T, Miarecki S, Middell E, Milke N, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Odrowski S, Olivas A, O'Murchadha A, Paul L, Pepper JA, Pérez de los Heros C, Pfendner C, Pieloth D, Pinat E, Posselt J, Price PB, Przybylski GT, Rädel L, Rameez M, Rawlins K, Redl P, Reimann R, Resconi E, Rhode W, Ribordy M, Richman M, Riedel B, Rodrigues JP, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Salameh T, Sander HG, Santander M, Sarkar S, Schatto K, Scheriau F, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönwald A, Schukraft A, Schulte L, Schulz O, Seckel D, Sestayo Y, Seunarine S, Shanidze R, Sheremata C, Smith MWE, Soldin D, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stasik A, Stezelberger T, Stokstad RG, Stößl A, Strahler EA, Ström R, Sullivan GW, Taavola H, Taboada I, Tamburro A, Tepe A, Ter-Antonyan S, Tešić G, Tilav S, Toale PA, Toscano S, Unger E, Usner M, van Eijndhoven N, Van Overloop A, van Santen J, Vehring M, Voge M, Vraeghe M, Walck C, Waldenmaier T, Wallraff M, Weaver C, Wellons M, Wendt C, Westerhoff S, Whitehorn N, Wiebe K, Wiebusch CH, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu DL, Xu XW, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Ziemann J, Zierke S, Zoll M. Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science 2013; 342:1242856. [PMID: 24264993 DOI: 10.1126/science.1242856] [Show More Authors] [Citation(s) in RCA: 181] [Impact Index Per Article: 15.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
We report on results of an all-sky search for high-energy neutrino events interacting within the IceCube neutrino detector conducted between May 2010 and May 2012. The search follows up on the previous detection of two PeV neutrino events, with improved sensitivity and extended energy coverage down to about 30 TeV. Twenty-six additional events were observed, substantially more than expected from atmospheric backgrounds. Combined, both searches reject a purely atmospheric origin for the 28 events at the 4σ level. These 28 events, which include the highest energy neutrinos ever observed, have flavors, directions, and energies inconsistent with those expected from the atmospheric muon and neutrino backgrounds. These properties are, however, consistent with generic predictions for an additional component of extraterrestrial origin.
Collapse
|
Research Support, U.S. Gov't, Non-P.H.S. |
12 |
181 |
8
|
Akerib DS, Alsum S, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Bramante R, Brás P, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chiller AA, Chiller C, Currie A, Cutter JE, Davison TJR, Dobi A, Dobson JEY, Druszkiewicz E, Edwards BN, Faham CH, Fiorucci S, Gaitskell RJ, Gehman VM, Ghag C, Gibson KR, Gilchriese MGD, Hall CR, Hanhardt M, Haselschwardt SJ, Hertel SA, Hogan DP, Horn M, Huang DQ, Ignarra CM, Ihm M, Jacobsen RG, Ji W, Kamdin K, Kazkaz K, Khaitan D, Knoche R, Larsen NA, Lee C, Lenardo BG, Lesko KT, Lindote A, Lopes MI, Manalaysay A, Mannino RL, Marzioni MF, McKinsey DN, Mei DM, Mock J, Moongweluwan M, Morad JA, Murphy ASJ, Nehrkorn C, Nelson HN, Neves F, O'Sullivan K, Oliver-Mallory KC, Palladino KJ, Pease EK, Phelps P, Reichhart L, Rhyne C, Shaw S, Shutt TA, Silva C, Solmaz M, Solovov VN, Sorensen P, Stephenson S, Sumner TJ, Szydagis M, Taylor DJ, Taylor WC, Tennyson BP, Terman PA, Tiedt DR, To WH, Tripathi M, Tvrznikova L, Uvarov S, Verbus JR, Webb RC, White JT, Whitis TJ, Witherell MS, Wolfs FLH, Xu J, Yazdani K, Young SK, et alAkerib DS, Alsum S, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Bramante R, Brás P, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chiller AA, Chiller C, Currie A, Cutter JE, Davison TJR, Dobi A, Dobson JEY, Druszkiewicz E, Edwards BN, Faham CH, Fiorucci S, Gaitskell RJ, Gehman VM, Ghag C, Gibson KR, Gilchriese MGD, Hall CR, Hanhardt M, Haselschwardt SJ, Hertel SA, Hogan DP, Horn M, Huang DQ, Ignarra CM, Ihm M, Jacobsen RG, Ji W, Kamdin K, Kazkaz K, Khaitan D, Knoche R, Larsen NA, Lee C, Lenardo BG, Lesko KT, Lindote A, Lopes MI, Manalaysay A, Mannino RL, Marzioni MF, McKinsey DN, Mei DM, Mock J, Moongweluwan M, Morad JA, Murphy ASJ, Nehrkorn C, Nelson HN, Neves F, O'Sullivan K, Oliver-Mallory KC, Palladino KJ, Pease EK, Phelps P, Reichhart L, Rhyne C, Shaw S, Shutt TA, Silva C, Solmaz M, Solovov VN, Sorensen P, Stephenson S, Sumner TJ, Szydagis M, Taylor DJ, Taylor WC, Tennyson BP, Terman PA, Tiedt DR, To WH, Tripathi M, Tvrznikova L, Uvarov S, Verbus JR, Webb RC, White JT, Whitis TJ, Witherell MS, Wolfs FLH, Xu J, Yazdani K, Young SK, Zhang C. Results from a Search for Dark Matter in the Complete LUX Exposure. PHYSICAL REVIEW LETTERS 2017; 118:021303. [PMID: 28128598 DOI: 10.1103/physrevlett.118.021303] [Show More Authors] [Citation(s) in RCA: 175] [Impact Index Per Article: 21.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/13/2016] [Indexed: 06/06/2023]
Abstract
We report constraints on spin-independent weakly interacting massive particle (WIMP)-nucleon scattering using a 3.35×10^{4} kg day exposure of the Large Underground Xenon (LUX) experiment. A dual-phase xenon time projection chamber with 250 kg of active mass is operated at the Sanford Underground Research Facility under Lead, South Dakota (USA). With roughly fourfold improvement in sensitivity for high WIMP masses relative to our previous results, this search yields no evidence of WIMP nuclear recoils. At a WIMP mass of 50 GeV c^{-2}, WIMP-nucleon spin-independent cross sections above 2.2×10^{-46} cm^{2} are excluded at the 90% confidence level. When combined with the previously reported LUX exposure, this exclusion strengthens to 1.1×10^{-46} cm^{2} at 50 GeV c^{-2}.
Collapse
|
|
8 |
175 |
9
|
Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, Palileo-Villaneuva L, Lopez-Jaramillo P, Karaye K, Yusoff K, Orlandini A, Sliwa K, Mondo C, Lanas F, Prabhakaran D, Badr A, Elmaghawry M, Damasceno A, Tibazarwa K, Belley-Cote E, Balasubramanian K, Islam S, Yacoub MH, Huffman MD, Harkness K, Grinvalds A, McKelvie R, Bangdiwala SI, Yusuf S, Campos R, Chacón C, Cursack G, Diez F, Escobar C, Garcia C, Vilamajo OG, Hominal M, Ingaramo A, Kucharczuk G, Pelliza M, Rojas A, Villani A, Zapata G, Bourke P, Lanas F, Nahuelpan L, Olivares C, Riquelme R, Ai F, Bai X, Chen X, Chen Y, Gao M, Ge C, He Y, Huang W, Jiang H, Liang T, Liang X, Liao Y, Liu S, Luo Y, Lu L, Qin S, Tan G, Tan H, Wang T, Wang X, Wei F, Xiao F, Zhang B, Zheng T, Mendoza JA, Anaya MB, Gomez E, de Salazar DM, Quiroz F, Rodríguez M, Sotomayor MS, Navas AT, León MB, Montalvo LF, Jaramillo ML, Patiño EP, Perugachi C, Trujillo Cruz F, Elmaghawry M, Wagdy K, Bhardwaj A, Chaturvedi V, Gokhale GK, Gupta R, Honnutagi R, Joshi P, Ladhani S, Negi P, Roy A, Reddy N, Abdullah A, Hassan MA, et alDokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, Palileo-Villaneuva L, Lopez-Jaramillo P, Karaye K, Yusoff K, Orlandini A, Sliwa K, Mondo C, Lanas F, Prabhakaran D, Badr A, Elmaghawry M, Damasceno A, Tibazarwa K, Belley-Cote E, Balasubramanian K, Islam S, Yacoub MH, Huffman MD, Harkness K, Grinvalds A, McKelvie R, Bangdiwala SI, Yusuf S, Campos R, Chacón C, Cursack G, Diez F, Escobar C, Garcia C, Vilamajo OG, Hominal M, Ingaramo A, Kucharczuk G, Pelliza M, Rojas A, Villani A, Zapata G, Bourke P, Lanas F, Nahuelpan L, Olivares C, Riquelme R, Ai F, Bai X, Chen X, Chen Y, Gao M, Ge C, He Y, Huang W, Jiang H, Liang T, Liang X, Liao Y, Liu S, Luo Y, Lu L, Qin S, Tan G, Tan H, Wang T, Wang X, Wei F, Xiao F, Zhang B, Zheng T, Mendoza JA, Anaya MB, Gomez E, de Salazar DM, Quiroz F, Rodríguez M, Sotomayor MS, Navas AT, León MB, Montalvo LF, Jaramillo ML, Patiño EP, Perugachi C, Trujillo Cruz F, Elmaghawry M, Wagdy K, Bhardwaj A, Chaturvedi V, Gokhale GK, Gupta R, Honnutagi R, Joshi P, Ladhani S, Negi P, Roy A, Reddy N, Abdullah A, Hassan MA, Balasinga M, Kasim S, Tan W, Yusoff K, Damasceno A, Banze R, Calua E, Novela C, Chemane J, Akintunde A, Ansa V, Gbadamosi H, Karaye K, Mbakwem A, Mohammed S, Nwafor E, Ojji D, Olunuga T, Sa'idu BOH, Umuerri E, Alcaraz J, Palileo-Villanueva L, Palomares E, Timonera MR, Badr A, Alghamdi S, Alhabib K, Almasood A, Alsaif S, Elasfar A, Ghabashi A, Mimish L, Bester F, Kelbe D, Klug E, Sliwa K, Tibarzawa K, Abdalla O, Dimitri M, Mustafa H, Osman O, Saad A, Mondo C. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. LANCET GLOBAL HEALTH 2017; 5:e665-e672. [DOI: 10.1016/s2214-109x(17)30196-1] [Show More Authors] [Citation(s) in RCA: 174] [Impact Index Per Article: 21.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/10/2017] [Revised: 04/10/2017] [Accepted: 04/26/2017] [Indexed: 12/13/2022]
|
|
8 |
174 |
10
|
Bai X, Peirson BN, Dong F, Xue C, Makaroff CA. Isolation and characterization of SYN1, a RAD21-like gene essential for meiosis in Arabidopsis. THE PLANT CELL 1999; 11:417-30. [PMID: 10072401 PMCID: PMC144192 DOI: 10.1105/tpc.11.3.417] [Citation(s) in RCA: 158] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
Abstract
The proper pairing, recombination, and segregation of chromosomes are central to meiosis and sexual reproduction. The syn1 mutation was previously identified as a synaptic mutant in a T-DNA-tagged population of plants. SYN1 has been isolated and found to exhibit similarity to Schizosaccharomyces pombe RAD21 and RAD21-like proteins, which are required for chromosome condensation and sister chromatid cohesion during mitosis. Plants homozygous for syn1 are male and female sterile and show defects in chromosome condensation and pairing beginning at leptonema of meiosis I. Fragmentation of the chromosomes was observed at metaphase I. Alternative promoters produced two SYN1 transcripts. One transcript was expressed at low levels in most tissues, whereas the other was expressed only in prebolting buds. DNA blot analyses suggest that Arabidopsis contains a small RAD21 gene family. Consistent with the DNA blot data, a second Arabidopsis RAD21-like gene has been identified. These results suggest that different RAD21-like proteins play essential roles in chromosome condensation and pairing during both meiosis and mitosis.
Collapse
|
research-article |
26 |
158 |
11
|
Aartsen MG, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Altmann D, Anderson T, Arguelles C, Arlen TC, Auffenberg J, Bai X, Barwick SW, Baum V, Beatty JJ, Becker Tjus J, Becker KH, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohm C, Bose D, Böser S, Botner O, Brayeur L, Bretz HP, Brown AM, Casey J, Casier M, Chirkin D, Christov A, Christy B, Clark K, Classen L, Clevermann F, Coenders S, Cowen DF, Cruz Silva AH, Danninger M, Daughhetee J, Davis JC, Day M, de André JPAM, De Clercq C, De Ridder S, Desiati P, de Vries KD, de With M, DeYoung T, Díaz-Vélez JC, Dunkman M, Eagan R, Eberhardt B, Eichmann B, Eisch J, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feintzeig J, Felde J, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Franckowiak A, Frantzen K, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Gier D, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grandmont DT, Grant D, Gretskov P, Groh JC, Groß A, Ha C, Haack C, Haj Ismail A, Hallen P, Hallgren A, et alAartsen MG, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Altmann D, Anderson T, Arguelles C, Arlen TC, Auffenberg J, Bai X, Barwick SW, Baum V, Beatty JJ, Becker Tjus J, Becker KH, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohm C, Bose D, Böser S, Botner O, Brayeur L, Bretz HP, Brown AM, Casey J, Casier M, Chirkin D, Christov A, Christy B, Clark K, Classen L, Clevermann F, Coenders S, Cowen DF, Cruz Silva AH, Danninger M, Daughhetee J, Davis JC, Day M, de André JPAM, De Clercq C, De Ridder S, Desiati P, de Vries KD, de With M, DeYoung T, Díaz-Vélez JC, Dunkman M, Eagan R, Eberhardt B, Eichmann B, Eisch J, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feintzeig J, Felde J, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Franckowiak A, Frantzen K, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Gier D, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grandmont DT, Grant D, Gretskov P, Groh JC, Groß A, Ha C, Haack C, Haj Ismail A, Hallen P, Hallgren A, Halzen F, Hanson K, Hebecker D, Heereman D, Heinen D, Helbing K, Hellauer R, Hellwig D, Hickford S, Hill GC, Hoffman KD, Hoffmann R, Homeier A, Hoshina K, Huang F, Huelsnitz W, Hulth PO, Hultqvist K, Hussain S, Ishihara A, Jacobi E, Jacobsen J, Jagielski K, Japaridze GS, Jero K, Jlelati O, Jurkovic M, Kaminsky B, Kappes A, Karg T, Karle A, Kauer M, Kelley JL, Kheirandish A, Kiryluk J, Kläs J, Klein SR, Köhne JH, Kohnen G, Kolanoski H, Koob A, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Kriesten A, Krings K, Kroll G, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Larsen DT, Larson MJ, Lesiak-Bzdak M, Leuermann M, Leute J, Lünemann J, Macías O, Madsen J, Maggi G, Maruyama R, Mase K, Matis HS, McNally F, Meagher K, Meli A, Meures T, Miarecki S, Middell E, Middlemas E, Milke N, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Odrowski S, Olivas A, Omairat A, O'Murchadha A, Palczewski T, Paul L, Penek O, Pepper JA, Pérez de Los Heros C, Pfendner C, Pieloth D, Pinat E, Posselt J, Price PB, Przybylski GT, Pütz J, Quinnan M, Rädel L, Rameez M, Rawlins K, Redl P, Rees I, Reimann R, Resconi E, Rhode W, Richman M, Riedel B, Robertson S, Rodrigues JP, Rongen M, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Sander HG, Santander M, Sarkar S, Schatto K, Scheriau F, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönwald A, Schukraft A, Schulte L, Schulz O, Seckel D, Sestayo Y, Seunarine S, Shanidze R, Sheremata C, Smith MWE, Soldin D, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stanisha NA, Stasik A, Stezelberger T, Stokstad RG, Stößl A, Strahler EA, Ström R, Strotjohann NL, Sullivan GW, Taavola H, Taboada I, Tamburro A, Tepe A, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale PA, Tobin MN, Tosi D, Tselengidou M, Unger E, Usner M, Vallecorsa S, van Eijndhoven N, Vandenbroucke J, van Santen J, Vehring M, Voge M, Vraeghe M, Walck C, Wallraff M, Weaver C, Wellons M, Wendt C, Westerhoff S, Whelan BJ, Whitehorn N, Wichary C, Wiebe K, Wiebusch CH, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu DL, Xu XW, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Ziemann J, Zierke S, Zoll M. Observation of high-energy astrophysical neutrinos in three years of IceCube data. PHYSICAL REVIEW LETTERS 2014; 113:101101. [PMID: 25238345 DOI: 10.1103/physrevlett.113.101101] [Show More Authors] [Citation(s) in RCA: 150] [Impact Index Per Article: 13.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2014] [Indexed: 06/03/2023]
Abstract
A search for high-energy neutrinos interacting within the IceCube detector between 2010 and 2012 provided the first evidence for a high-energy neutrino flux of extraterrestrial origin. Results from an analysis using the same methods with a third year (2012-2013) of data from the complete IceCube detector are consistent with the previously reported astrophysical flux in the 100 TeV-PeV range at the level of 10(-8) GeV cm-2 s-1 sr-1 per flavor and reject a purely atmospheric explanation for the combined three-year data at 5.7σ. The data are consistent with expectations for equal fluxes of all three neutrino flavors and with isotropic arrival directions, suggesting either numerous or spatially extended sources. The three-year data set, with a live time of 988 days, contains a total of 37 neutrino candidate events with deposited energies ranging from 30 to 2000 TeV. The 2000-TeV event is the highest-energy neutrino interaction ever observed.
Collapse
|
|
11 |
150 |
12
|
Andrés E, Askebjer P, Bai X, Barouch G, Barwick SW, Bay RC, Becker KH, Bergström L, Bertrand D, Bierenbaum D, Biron A, Booth J, Botner O, Bouchta A, Boyce MM, Carius S, Chen A, Chirkin D, Conrad J, Cooley J, Costa CG, Cowen DF, Dailing J, Dalberg E, DeYoung T, Desiati P, Dewulf JP, Doksus P, Edsjö J, Ekström P, Erlandsson B, Feser T, Gaug M, Goldschmidt A, Goobar A, Gray L, Haase H, Hallgren A, Halzen F, Hanson K, Hardtke R, He YD, Hellwig M, Heukenkamp H, Hill GC, Hulth PO, Hundertmark S, Jacobsen J, Kandhadai V, Karle A, Kim J, Koci B, Köpke L, Kowalski M, Leich H, Leuthold M, Lindahl P, Liubarsky I, Loaiza P, Lowder DM, Ludvig J, Madsen J, Marciniewski P, Matis HS, Mihalyi A, Mikolajski T, Miller TC, Minaeva Y, Miocinović P, Mock PC, Morse R, Neunhöffer T, Newcomer FM, Niessen P, Nygren DR, Ogelman H, Pérez de los Heros C, Porrata R, Price PB, Rawlins K, Reed C, Rhode W, Richards A, Richter S, Martino JR, Romenesko P, Ross D, Rubinstein H, Sander HG, Scheider T, Schmidt T, Schneider D, Schneider E, Schwarz R, Silvestri A, Solarz M, Spiczak GM, Spiering C, Starinsky N, Steele D, et alAndrés E, Askebjer P, Bai X, Barouch G, Barwick SW, Bay RC, Becker KH, Bergström L, Bertrand D, Bierenbaum D, Biron A, Booth J, Botner O, Bouchta A, Boyce MM, Carius S, Chen A, Chirkin D, Conrad J, Cooley J, Costa CG, Cowen DF, Dailing J, Dalberg E, DeYoung T, Desiati P, Dewulf JP, Doksus P, Edsjö J, Ekström P, Erlandsson B, Feser T, Gaug M, Goldschmidt A, Goobar A, Gray L, Haase H, Hallgren A, Halzen F, Hanson K, Hardtke R, He YD, Hellwig M, Heukenkamp H, Hill GC, Hulth PO, Hundertmark S, Jacobsen J, Kandhadai V, Karle A, Kim J, Koci B, Köpke L, Kowalski M, Leich H, Leuthold M, Lindahl P, Liubarsky I, Loaiza P, Lowder DM, Ludvig J, Madsen J, Marciniewski P, Matis HS, Mihalyi A, Mikolajski T, Miller TC, Minaeva Y, Miocinović P, Mock PC, Morse R, Neunhöffer T, Newcomer FM, Niessen P, Nygren DR, Ogelman H, Pérez de los Heros C, Porrata R, Price PB, Rawlins K, Reed C, Rhode W, Richards A, Richter S, Martino JR, Romenesko P, Ross D, Rubinstein H, Sander HG, Scheider T, Schmidt T, Schneider D, Schneider E, Schwarz R, Silvestri A, Solarz M, Spiczak GM, Spiering C, Starinsky N, Steele D, Steffen P, Stokstad RG, Streicher O, Sun Q, Taboada I, Thollander L, Thon T, Tilav S, Usechak N, Vander Donckt M, Walck C, Weinheimer C, Wiebusch CH, Wischnewski R, Wissing H, Woschnagg K, Wu W, Yodh G, Young S. Observation of high-energy neutrinos using Cerenkov detectors embedded deep in Antarctic ice. Nature 2001; 410:441-3. [PMID: 11260705 DOI: 10.1038/35068509] [Show More Authors] [Citation(s) in RCA: 138] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Neutrinos are elementary particles that carry no electric charge and have little mass. As they interact only weakly with other particles, they can penetrate enormous amounts of matter, and therefore have the potential to directly convey astrophysical information from the edge of the Universe and from deep inside the most cataclysmic high-energy regions. The neutrino's great penetrating power, however, also makes this particle difficult to detect. Underground detectors have observed low-energy neutrinos from the Sun and a nearby supernova, as well as neutrinos generated in the Earth's atmosphere. But the very low fluxes of high-energy neutrinos from cosmic sources can be observed only by much larger, expandable detectors in, for example, deep water or ice. Here we report the detection of upwardly propagating atmospheric neutrinos by the ice-based Antarctic muon and neutrino detector array (AMANDA). These results establish a technology with which to build a kilometre-scale neutrino observatory necessary for astrophysical observations.
Collapse
|
|
24 |
138 |
13
|
Brown JT, Bai X, Johnson AW. The yeast antiviral proteins Ski2p, Ski3p, and Ski8p exist as a complex in vivo. RNA (NEW YORK, N.Y.) 2000; 6:449-57. [PMID: 10744028 PMCID: PMC1369926 DOI: 10.1017/s1355838200991787] [Citation(s) in RCA: 129] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
The yeast superkiller (SKI) genes were originally identified from mutations allowing increased production of killer toxin encoded by M "killer" virus, a satellite of the dsRNA virus L-A. XRN1 (SKI1) encodes a cytoplasmic 5'-exoribonuclease responsible for the majority of cytoplasmic RNA turnover, whereas SKI2, SKI3, and SKI8 are required for normal 3'-degradation of mRNA and for repression of translation of poly(A) minus RNA. Ski2p is a putative RNA helicase, Ski3p is a tetratricopeptide repeat (TPR) protein, and Ski8p contains five WD-40 (beta-transducin) repeats. An xrn1 mutation in combination with a ski2, ski3, or ski8 mutation is lethal, suggesting redundancy of function. Using functional epitope-tagged Ski2, Ski3, and Ski8 proteins, we show that Ski2p, Ski3p, and Ski8p can be coimmunoprecipitated as an apparent heterotrimeric complex. With epitope-tagged Ski2p, there was a 1:1:1 stoichiometry of the proteins in the complex. Ski2p did not associate with Ski3p in the absence of Ski8p, nor did Ski2p associate with Ski8p in the absence of Ski3p. However, the Ski3p/Ski8p interaction did not require Ski2p. In addition, ski6-2 or ski4-1 mutations or deletion of SKI7 did not affect complex formation. The identification of a complex composed of Ski2p, Ski3p, and Ski8p explains previous results showing phenotypic similarity between mutations in SKI2, SKI3, and SKI8. Indirect immunofluorescence of Ski3p and subcellular fractionation of Ski2p and Ski3p suggest that Ski2p and Ski3p are cytoplasmic. These data support the idea that Ski2p, Ski3p, and Ski8p function in the cytoplasm in a 3'-mRNA degradation pathway.
Collapse
|
research-article |
25 |
129 |
14
|
Yang JJ, Zhou Q, Yan HH, Zhang XC, Chen HJ, Tu HY, Wang Z, Xu CR, Su J, Wang BC, Jiang BY, Bai XY, Zhong WZ, Yang XN, Wu YL. A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations. Br J Cancer 2017; 116:568-574. [PMID: 28103612 PMCID: PMC5344291 DOI: 10.1038/bjc.2016.456] [Citation(s) in RCA: 128] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2016] [Revised: 12/18/2016] [Accepted: 12/22/2016] [Indexed: 01/14/2023] Open
Abstract
Background: A phase III trial was conducted to compare the safety and efficacy of erlotinib with that of gefitinib in advanced non-small cell lung cancer harbouring epidermal growth factor receptor mutations in exon 19 or 21. Methods: Eligible patients were randomised to receive erlotinib (150 mg per day) or gefitinib (250 mg per day) orally until disease progression or unacceptable toxicity. We aimed to determine whether erlotinib is superior to gefitinib in efficacy. The primary end point was progression-free survival. Results: A total of 256 patients were randomised to receive erlotinib (N=128) or gefitinib (N=128). Median progression-free survival was not better with erlotinib than with gefitinib (13.0 vs 10.4 months, 95% confidence interval (CI) 0.62–1.05, P=0.108). The corresponding response rates and median overall survival were 56.3% vs 52.3% (P=0.530) and 22.9 vs 20.1 months (95% CI 0.63–1.13, P=0.250), respectively. There were no significant differences in grade 3/4 toxicities between the two arms (P=0.172). Conclusions: The primary end point was not met. Erlotinib was not significantly superior to gefitinib in terms of efficacy in advanced non-small cell lung cancer with epidermal growth factor receptor mutations in exon 19 or 21, and the two treatments had similar toxicities.
Collapse
|
Randomized Controlled Trial |
8 |
128 |
15
|
Ackermann M, Ahrens J, Bai X, Bartelt M, Barwick SW, Bay RC, Becka T, Becker JK, Becker KH, Berghaus P, Bernardini E, Bertrand D, Boersma DJ, Böser S, Botner O, Bouchta A, Bouhali O, Burgess C, Burgess T, Castermans T, Chirkin D, Collin B, Conrad J, Cooley J, Cowen DF, Davour A, De Clercq C, de los Heros CP, Desiati P, DeYoung T, Ekström P, Feser T, Gaisser TK, Ganugapati R, Geenen H, Gerhardt L, Goldschmidt A, Groß A, Hallgren A, Halzen F, Hanson K, Hardtke DH, Harenberg T, Hauschildt T, Helbing K, Hellwig M, Herquet P, Hill GC, Hodges J, Hubert D, Hughey B, Hulth PO, Hultqvist K, Hundertmark S, Jacobsen J, Kampert KH, Karle A, Kestel M, Kohnen G, Köpke L, Kowalski M, Kuehn K, Lang R, Leich H, Leuthold M, Liubarsky I, Lundberg J, Madsen J, Marciniewski P, Matis HS, McParland CP, Messarius T, Minaeva Y, Miočinović P, Morse R, Münich K, Nahnhauer R, Nam JW, Neunhöffer T, Niessen P, Nygren DR, Olbrechts P, Pohl AC, Porrata R, Price PB, Przybylski GT, Rawlins K, Resconi E, Rhode W, Ribordy M, Richter S, Rodríguez Martino J, Sander HG, Schlenstedt S, Schneider D, Schwarz R, Silvestri A, Solarz M, Spiczak GM, Spiering C, et alAckermann M, Ahrens J, Bai X, Bartelt M, Barwick SW, Bay RC, Becka T, Becker JK, Becker KH, Berghaus P, Bernardini E, Bertrand D, Boersma DJ, Böser S, Botner O, Bouchta A, Bouhali O, Burgess C, Burgess T, Castermans T, Chirkin D, Collin B, Conrad J, Cooley J, Cowen DF, Davour A, De Clercq C, de los Heros CP, Desiati P, DeYoung T, Ekström P, Feser T, Gaisser TK, Ganugapati R, Geenen H, Gerhardt L, Goldschmidt A, Groß A, Hallgren A, Halzen F, Hanson K, Hardtke DH, Harenberg T, Hauschildt T, Helbing K, Hellwig M, Herquet P, Hill GC, Hodges J, Hubert D, Hughey B, Hulth PO, Hultqvist K, Hundertmark S, Jacobsen J, Kampert KH, Karle A, Kestel M, Kohnen G, Köpke L, Kowalski M, Kuehn K, Lang R, Leich H, Leuthold M, Liubarsky I, Lundberg J, Madsen J, Marciniewski P, Matis HS, McParland CP, Messarius T, Minaeva Y, Miočinović P, Morse R, Münich K, Nahnhauer R, Nam JW, Neunhöffer T, Niessen P, Nygren DR, Olbrechts P, Pohl AC, Porrata R, Price PB, Przybylski GT, Rawlins K, Resconi E, Rhode W, Ribordy M, Richter S, Rodríguez Martino J, Sander HG, Schlenstedt S, Schneider D, Schwarz R, Silvestri A, Solarz M, Spiczak GM, Spiering C, Stamatikos M, Steele D, Steffen P, Stokstad RG, Sulanke KH, Taboada I, Tarasova O, Thollander L, Tilav S, Wagner W, Walck C, Walter M, Wang YR, Wiebusch CH, Wischnewski R, Wissing H, Woschnagg K. Optical properties of deep glacial ice at the South Pole. ACTA ACUST UNITED AC 2006. [DOI: 10.1029/2005jd006687] [Show More Authors] [Citation(s) in RCA: 122] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
19 |
122 |
16
|
Bai X, Zhou D, Brown JR, Crawford BE, Hennet T, Esko JD. Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6). J Biol Chem 2001; 276:48189-95. [PMID: 11551958 DOI: 10.1074/jbc.m107339200] [Citation(s) in RCA: 121] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
A family of five beta1,3-galactosyltransferases has been characterized that catalyze the formation of Galbeta1,3GlcNAcbeta and Galbeta1,3GalNAcbeta linkages present in glycoproteins and glycolipids (beta3GalT1, -2, -3, -4, and -5). We now report a new member of the family (beta3GalT6), involved in glycosaminoglycan biosynthesis. The human and mouse genes were located on chromosomes 1p36.3 and 4E2, respectively, and homologs are found in Drosophila melanogaster and Caenorhabditis elegans. Unlike other members of the family, beta3GalT6 showed a broad mRNA expression pattern by Northern blot analysis. Although a high degree of homology across several subdomains exists among other members of the beta3-galactosyltransferase family, recombinant enzyme did not utilize glucosamine- or galactosamine-containing acceptors. Instead, the enzyme transferred galactose from UDP-galactose to acceptors containing a terminal beta-linked galactose residue. This product, Galbeta1,3Galbeta is found in the linkage region of heparan sulfate and chondroitin sulfate (GlcAbeta1,3Galbeta1,3Galbeta1,4Xylbeta-O-Ser), indicating that beta3GalT6 is the so-called galactosyltransferase II involved in glycosaminoglycan biosynthesis. Its identity was confirmed in vivo by siRNA-mediated inhibition of glycosaminoglycan synthesis in HeLa S3 cells. Its localization in the medial Golgi indicates that this is the major site for assembly of the linkage region.
Collapse
|
|
24 |
121 |
17
|
Miao D, Bai X, Panda D, McKee M, Karaplis A, Goltzman D. Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition. Endocrinology 2001; 142:926-39. [PMID: 11159866 DOI: 10.1210/endo.142.2.7976] [Citation(s) in RCA: 116] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
To explore how the loss of Phex function contributes to the pathogenesis of osteomalacia, we examined the abnormalities of mineralization, Phex, and bone matrix protein expression occurring in Hyp mice in vivo and in ex vivo bone marrow cell cultures. The results in vivo show that mineralization was decreased significantly in Hyp mouse bone. Phex protein was identifiable in osteoblasts and osteocytes in wild-type mice, but not in Hyp mice. In Hyp mice, osteocalcin, bone sialoprotein, and vitronectin expression were down-regulated, whereas biglycan and fibrillin-1 expression were up-regulated in osteocytes and bone matrix relative to those in their wild-type counterparts. Parallel studies ex vivo demonstrated that cells derived from 18-day Hyp mouse bone marrow cell cultures had a 3'-Phex deletion, no Phex protein expression, decreased alkaline phosphatase activity, collagen deposition, and calcium accumulation, and reduced osteocalcin, bone sialoprotein, and vitronectin at both the protein and messenger RNA levels. Furthermore conditioned medium from Hyp mouse bone marrow cultures could induce analogous defects in bone marrow cell cultures of wild-type cells. These novel findings indicate that there is an intrinsic osteogenic cell differentiation defect in addition to the known hypomineralization of bone in Hyp mice, which may be inducible by an autocrine/paracrine secreted factor. These results suggest that alterations in the Phex gene may control bone matrix mineralization indirectly by regulating the synthesis and deposition of bone matrix proteins.
Collapse
|
|
24 |
116 |
18
|
Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Bedikian S, Bernard E, Bernstein A, Bolozdynya A, Bradley A, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chapman JJ, Chiller AA, Chiller C, Clark K, Coffey T, Currie A, Curioni A, Dazeley S, de Viveiros L, Dobi A, Dobson J, Dragowsky EM, Druszkiewicz E, Edwards B, Faham CH, Fiorucci S, Flores C, Gaitskell RJ, Gehman VM, Ghag C, Gibson KR, Gilchriese MGD, Hall C, Hanhardt M, Hertel SA, Horn M, Huang DQ, Ihm M, Jacobsen RG, Kastens L, Kazkaz K, Knoche R, Kyre S, Lander R, Larsen NA, Lee C, Leonard DS, Lesko KT, Lindote A, Lopes MI, Lyashenko A, Malling DC, Mannino R, McKinsey DN, Mei DM, Mock J, Moongweluwan M, Morad J, Morii M, Murphy ASJ, Nehrkorn C, Nelson H, Neves F, Nikkel JA, Ott RA, Pangilinan M, Parker PD, Pease EK, Pech K, Phelps P, Reichhart L, Shutt T, Silva C, Skulski W, Sofka CJ, Solovov VN, Sorensen P, Stiegler T, O'Sullivan K, Sumner TJ, Svoboda R, Sweany M, Szydagis M, Taylor D, Tennyson B, Tiedt DR, Tripathi M, Uvarov S, Verbus JR, Walsh N, Webb R, White JT, White D, Witherell MS, Wlasenko M, Wolfs FLH, et alAkerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J, Bedikian S, Bernard E, Bernstein A, Bolozdynya A, Bradley A, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chapman JJ, Chiller AA, Chiller C, Clark K, Coffey T, Currie A, Curioni A, Dazeley S, de Viveiros L, Dobi A, Dobson J, Dragowsky EM, Druszkiewicz E, Edwards B, Faham CH, Fiorucci S, Flores C, Gaitskell RJ, Gehman VM, Ghag C, Gibson KR, Gilchriese MGD, Hall C, Hanhardt M, Hertel SA, Horn M, Huang DQ, Ihm M, Jacobsen RG, Kastens L, Kazkaz K, Knoche R, Kyre S, Lander R, Larsen NA, Lee C, Leonard DS, Lesko KT, Lindote A, Lopes MI, Lyashenko A, Malling DC, Mannino R, McKinsey DN, Mei DM, Mock J, Moongweluwan M, Morad J, Morii M, Murphy ASJ, Nehrkorn C, Nelson H, Neves F, Nikkel JA, Ott RA, Pangilinan M, Parker PD, Pease EK, Pech K, Phelps P, Reichhart L, Shutt T, Silva C, Skulski W, Sofka CJ, Solovov VN, Sorensen P, Stiegler T, O'Sullivan K, Sumner TJ, Svoboda R, Sweany M, Szydagis M, Taylor D, Tennyson B, Tiedt DR, Tripathi M, Uvarov S, Verbus JR, Walsh N, Webb R, White JT, White D, Witherell MS, Wlasenko M, Wolfs FLH, Woods M, Zhang C. First results from the LUX dark matter experiment at the Sanford underground research facility. PHYSICAL REVIEW LETTERS 2014; 112:091303. [PMID: 24655239 DOI: 10.1103/physrevlett.112.091303] [Show More Authors] [Citation(s) in RCA: 116] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/30/2013] [Indexed: 06/03/2023]
Abstract
The Large Underground Xenon (LUX) experiment is a dual-phase xenon time-projection chamber operating at the Sanford Underground Research Facility (Lead, South Dakota). The LUX cryostat was filled for the first time in the underground laboratory in February 2013. We report results of the first WIMP search data set, taken during the period from April to August 2013, presenting the analysis of 85.3 live days of data with a fiducial volume of 118 kg. A profile-likelihood analysis technique shows our data to be consistent with the background-only hypothesis, allowing 90% confidence limits to be set on spin-independent WIMP-nucleon elastic scattering with a minimum upper limit on the cross section of 7.6 × 10(-46) cm(2) at a WIMP mass of 33 GeV/c(2). We find that the LUX data are in disagreement with low-mass WIMP signal interpretations of the results from several recent direct detection experiments.
Collapse
|
|
11 |
116 |
19
|
dos Santos CC, Han B, Andrade CF, Bai X, Uhlig S, Hubmayr R, Tsang M, Lodyga M, Keshavjee S, Slutsky AS, Liu M. DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFalpha, LPS, and cyclic stretch. Physiol Genomics 2004; 19:331-42. [PMID: 15454581 DOI: 10.1152/physiolgenomics.00153.2004] [Citation(s) in RCA: 113] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Recent evidence suggests that alveolar epithelial cells (AECs) may contribute to the development, propagation, and resolution of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Proinflammatory cytokines, pathogen products, and injurious mechanical ventilation are important contributors of excessive inflammatory responses in the lung. In the present study, we used cDNA microarrays to define the gene expression patterns of A549 cells (an AEC line) in the early stages of three models of pulmonary parenchymal cell activation: cells treated with tumor necrosis factor-alpha (TNFalpha) (20 ng/ml), lipopolysaccharide (LPS, 1 microg/ml), or cyclic stretch (20% elongation) for either 1 h or 4 h. Differential gene expression profiles were determined by gene array analysis. TNFalpha induced an inflammatory response pattern, including induction of genes for chemokines, inflammatory mediators, and cell surface membrane proteins. TNFalpha also increased genes related to pro- and anti-apoptotic proteins, signal transduction proteins, and transcriptional factors. TNFalpha further induced a group of genes that may form a negative feedback loop to silence the NFkappaB pathway. Stimulation of AECs with mechanical stretch changed cell morphology and activated Src protein tyrosine kinase. The combination of TNFalpha plus stretch enhanced or attenuated expression of multiple genes. LPS decreased microfilament polymerization but had less impact on NFkappaB translocation and gene expression. Results from this study indicate that AECs can tailor their response to different stimuli or/and combination of stimuli and subsequently play an important role in acute inflammatory responses in the lung.
Collapse
|
Research Support, Non-U.S. Gov't |
21 |
113 |
20
|
Chen Y, Harry A, Li J, Smit MJ, Bai X, Magnusson R, Pieroni JP, Weng G, Iyengar R. Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Galphas stimulation. Proc Natl Acad Sci U S A 1997; 94:14100-4. [PMID: 9391159 PMCID: PMC28439 DOI: 10.1073/pnas.94.25.14100] [Citation(s) in RCA: 109] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Receptors activate adenylyl cyclases through the Galphas subunit. Previous studies from our laboratory have shown in certain cell types that express adenylyl cyclase 6 (AC6), heterologous desensitization included reduction of the capability of adenylyl cyclases to be stimulated by Galphas. Here we further analyze protein kinase A (PKA) effects on adenylyl cyclases. PKA treatment of recombinant AC6 in insect cell membranes results in a selective loss of stimulation by high (>10 nM) concentrations of Galphas. Similar treatment of AC1 or AC2 did not affect Galphas stimulation. Conversion of Ser-674 in AC6 to an Ala blocks PKA phosphorylation and PKA-mediated loss of Galphas stimulation. A peptide encoding the region 660-682 of AC6 blocks stimulation of AC6 and AC2 by high concentrations of Galphas. Substitution of Ser-674 to Asp in the peptide renders the peptide ineffective, indicating that the region 660-682 of AC6 is involved in regulation of signal transfer from Galphas. This region contains a conserved motif present in most adenylyl cyclases; however, the PKA phosphorylation site is unique to members of the AC6 family. These observations suggest a mechanism of how isoform selective regulatory diversity can be obtained within conserved regions involved in signal communication.
Collapse
|
research-article |
28 |
109 |
21
|
Bai X, Esko JD. An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation. J Biol Chem 1996; 271:17711-7. [PMID: 8663454 DOI: 10.1074/jbc.271.30.17711] [Citation(s) in RCA: 103] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
The interaction of heparan sulfate with protein ligands depends on unique oligosaccharide sequences containing iduronic acid (IdUA), N-sulfated glucosamine residues, and O-sulfated sugars. To study the role of O-sulfation in greater detail, we isolated a Chinese hamster ovary cell mutant defective in 2-O-sulfation of iduronic acid. The mutant, pgsF-17, was identified by a colony blotting assay in which colonies of mutagen-treated cells were replica plated to two disks of polyester cloth. One disk was blotted with 125I-labeled basic fibroblast growth factor (bFGF) to measure binding to cell surface proteoglycans. The other disk was incubated with 35SO4 to measure proteoglycan biosynthesis. Autoradiography revealed a colony that did not bind 125I-bFGF, but incorporated 35SO4 normally (mutant pgsF-17). Complete deaminative cleavage of heparan sulfate revealed that material from pgsF-17 lacked IdUA(2OSO3)-GlcNSO3 and IdUA(2OSO3)-GlcNSO3(6OSO3), but contained a higher proportion of glucuronic acid GlcUA-GlcNSO3(6OSO3) and IdUA-GlcNSO3(6OSO3). Assay of the 2-O-sulfotransferase that acts on IdUA residues showed that mutant 17 lacked enzyme activity. Interestingly, the alteration resulted in accumulation of GlcNSO3 groups, suggesting that under normal conditions 2-O-sulfation decreases GlcNAc N-deacetylation/N-sulfation, and that the reactions occur simultaneously. The formation of IdUA and 6-O-sulfated glucosaminyl residues appears to be independent of 2-O-sulfation. pgsF-17 also lacks 2-O-sulfated GlcUA residues, suggesting that the same enzyme is responsible for 2-O-sulfation of IdUA and GlcUA residues. Mutant 17 provides a useful tool for studying the regulation of heparan sulfate biosynthesis and the relationship of heparan sulfate fine structure to its biological function.
Collapse
|
|
29 |
103 |
22
|
Xue Y, Bai X, Lee I, Kallstrom G, Ho J, Brown J, Stevens A, Johnson AW. Saccharomyces cerevisiae RAI1 (YGL246c) is homologous to human DOM3Z and encodes a protein that binds the nuclear exoribonuclease Rat1p. Mol Cell Biol 2000; 20:4006-15. [PMID: 10805743 PMCID: PMC85771 DOI: 10.1128/mcb.20.11.4006-4015.2000] [Citation(s) in RCA: 97] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The RAT1 gene of Saccharomyces cerevisiae encodes a 5'-->3' exoribonuclease which plays an essential role in yeast RNA degradation and/or processing in the nucleus. We have cloned a previously uncharacterized gene (YGL246c) that we refer to as RAI1 (Rat1p interacting protein 1). RAI1 is homologous to Caenorhabditis elegans DOM-3 and human DOM3Z. Deletion of RAI1 confers a growth defect which can be complemented by an additional copy of RAT1 on a centromeric vector or by directing Xrn1p, the cytoplasmic homolog of Rat1p, to the nucleus through the addition of a nuclear targeting sequence. Deletion of RAI1 is synthetically lethal with the rat1-1(ts) mutation and shows genetic interaction with a deletion of SKI2 but not XRN1. Polysome analysis of an rai1 deletion mutant indicated a defect in 60S biogenesis which was nearly fully reversed by high-copy RAT1. Northern blot analysis of rRNAs revealed that rai1 is required for normal 5.8S processing. In the absence of RAI1, 5.8S(L) was the predominant form of 5.8S and there was an accumulation of 3'-extended forms but not 5'-extended species of 5. 8S. In addition, a 27S pre-rRNA species accumulated in the rai1 mutant. Thus, deletion of RAI1 affects both 5' and 3' processing reactions of 5.8S rRNA. Consistent with the in vivo data suggesting that RAI1 enhances RAT1 function, purified Rai1p stabilized the in vitro exoribonuclease activity of Rat1p.
Collapse
|
research-article |
25 |
97 |
23
|
Zaller N, Nelson KE, Ness P, Wen G, Bai X, Shan H. Knowledge, attitude and practice survey regarding blood donation in a Northwestern Chinese city. Transfus Med 2005; 15:277-86. [PMID: 16101805 DOI: 10.1111/j.0958-7578.2005.00589.x] [Citation(s) in RCA: 97] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Recruitment of low-risk blood donors in developing countries is challenging. We studied the attitudes towards blood donation in several populations in a city in Western China. A survey of knowledge, attitude and practice was performed including 1280 individuals from eight distinct populations in Urumqi, Xinjiang Uyghur Autonomous Region, China. Included were Han Chinese and Uyghur populations of blood donors, non-donors, injection drug users, students and factory workers. Knowledge about blood donation varied between the groups. Factors motivating blood donation included social pressure, desire to know screening results and altruism. Inhibiting factors included fear of contracting an infection and other adverse health effects, including loss of vitality. Misconceptions about the effects of blood donation are widespread, even among educated persons in Urumqi. Fear of acquiring a serious infection may have been increased by the reports of HIV acquisition during plasma donations in China.
Collapse
|
Research Support, U.S. Gov't, P.H.S. |
20 |
97 |
24
|
Wong-Riley MT, Bai X, Buchmann E, Whelan HT. Light-emitting diode treatment reverses the effect of TTX on cytochrome oxidase in neurons. Neuroreport 2001; 12:3033-7. [PMID: 11568632 DOI: 10.1097/00001756-200110080-00011] [Citation(s) in RCA: 94] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Light close to and in the near-infrared range has documented benefits for promoting wound healing in human and animals. However, mechanisms of its action on cells are poorly understood. We hypothesized that light treatment with a light-emitting diode array at 670 nm (LED) is therapeutic in stimulating cellular events involving increases in cytochrome oxidase activity. LED was administered to cultured primary neurons whose voltage-dependent sodium channels were blocked by tetrodotoxin. The down-regulation of cytochrome oxidase activity by TTX was reverted to control levels by LED. LED alone also up-regulated enzyme activity. Thus, the results are consistent with our hypothesis that LED has a stimulating effect on cytochrome oxidase in neurons, even when they have been functionally silenced by TTX.
Collapse
|
|
24 |
94 |
25
|
Bai X, Wei G, Sinha A, Esko JD. Chinese hamster ovary cell mutants defective in glycosaminoglycan assembly and glucuronosyltransferase I. J Biol Chem 1999; 274:13017-24. [PMID: 10224052 DOI: 10.1074/jbc.274.19.13017] [Citation(s) in RCA: 93] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The proteoglycans of animal cells typically contain one or more heparan sulfate or chondroitin sulfate chains. These glycosaminoglycans assemble on a tetrasaccharide primer, -GlcAbeta1, 3Galbeta1,3Galbeta1,4Xylbeta-O-, attached to specific serine residues in the core protein. Studies of Chinese hamster ovary cell mutants defective in the first or second enzymes of the pathway (xylosyltransferase and galactosyltransferase I) show that the assembly of the primer occurs by sequential transfer of single monosaccharide residues from the corresponding high energy nucleotide sugar donor to the non-reducing end of the growing chain. In order to study the other reactions involved in linkage tetrasaccharide assembly, we have devised a powerful selection method based on induced resistance to a mitotoxin composed of basic fibroblast growth factor-saporin. One class of mutants does not incorporate 35SO4 and [6-3H]GlcN into glycosaminoglycan chains. Incubation of these cells with naphthol-beta-D-xyloside (Xylbeta-O-Np) resulted in accumulation of linkage region intermediates containing 1 or 2 mol of galactose (Galbeta1, 4Xylbeta-O-Np and Galbeta1, 3Galbeta1, 4Xylbeta-O-Np) and sialic acid (Siaalpha2,3Galbeta1, 3Galbeta1, 4Xylbeta-O-Np) but not any GlcA-containing oligosaccharides. Extracts of the mutants completely lacked UDP-glucuronic acid:Galbeta1,3Gal-R glucuronosyltransferase (GlcAT-I) activity, as measured by the transfer of GlcA from UDP-GlcA to Galbeta1,3Galbeta-O-naphthalenemethanol (<0.2 versus 3.6 pmol/min/mg). The mutation most likely lies in the structural gene encoding GlcAT-I since transfection of the mutant with a cDNA for GlcAT-I completely restored enzyme activity and glycosaminoglycan synthesis. These findings suggest that a single GlcAT effects the biosynthesis of common linkage region of both heparan sulfate and chondroitin sulfate in Chinese hamster ovary cells.
Collapse
|
|
26 |
93 |